Diadexus Inc (DDXSQ)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO, CA 94080

Diadexus Inc. is a life sciences company focused on the development and commercialization of patent-protected in vitro diagnostic products in cardiovascular disease. Co.'s PLAC Test for Lp-PLA2 (lipoprotein-associated phospholipase A2) provides information to help identify individuals at increased risk of suffering a heart attack or stroke. Co.'s PLAC Tests are blood tests that measure Lp-PLA2 levels.

Data as of 2020-08-01
Market Cap410.01 Shares Outstanding4.1 Million Avg 30-day Volume27
P/E Ratio Dividend Yield EPS-1.98
Price/Sales Price cash flow ratio Price free cash flow ratio
Book Value-1.53 Price to Tangible Book0.0 Alpha0.32
Short Interest Ratio0.0 % Short Interest to Float R-squared0.050993
BETA-11.5528 52-week High/Low0.025 / 0.0001 Stddev1.75676
View SEC Filings from DDXSQ instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 0 0 (0.0%)
13F Filers holding this stock: 1 0 (0.0%)
Aggregate 13F shares on 03/31/2020: 6 0
Aggregate 13F shares on 12/31/2019: 6 0
Percent change: 0.00%
Funds creating new positions:
Funds Adding to an existing position:
Funds closing out their position:
Funds reducing their position:
1 hedge funds as identified by whalewisdom.com through public filings.

Funds Holding DDXSQ (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding DDXSQ BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments